Search results for "drugs"

A Milestone for K-Bio: Celltrion’s Truxima Surpasses Global Blockbuster Rituxan in U.S. Prescriptions

A Milestone for K-Bio: Celltrion’s Truxima Surpasses Global Blockbuster Rituxan in U.S. Prescriptions

Truxima , a blood cancer treatment developed by Celltrion, has become the first Korean-made biosimilar to rank number one in prescription market...
Will Curocell’s First CAR-T Blood Cancer Drug Secure Approval Next Month?

Will Curocell’s First CAR-T Blood Cancer Drug Secure Approval Next Month?

A final decision on the approval of RIMQARTO (anbalcabtagene autoleucel), a chimeric antigen receptor T-cell (CAR-T) therapy developed by Curocell,...
Why Does the Same Chemotherapy Work Differently for Everyone? Cause of Treatment Failure Identified

Why Does the Same Chemotherapy Work Differently for Everyone? Cause of Treatment Failure Identified

Why is it that when given the same chemotherapy drug, some patients see remarkable recovery while others show no...
“Do pharmacies stay open on holidays, too?” A checklist for foreigners

“Do pharmacies stay open on holidays, too?” A checklist for foreigners

One of the things foreign visitors to South Korea are often amazed by is that they can get medicine even on weekends or...
Can Wegovy and Mounjaro Reduce Cancer Risk?

Can Wegovy and Mounjaro Reduce Cancer Risk?

Global obesity experts have proposed a large-scale, long-term follow-up study to verify whether the use of modern...
Celltrion to Double Production Capacity with 1.2 Trillion Won Investment

Celltrion to Double Production Capacity with 1.2 Trillion Won Investment

Celltrion has announced a massive expansion across three of its major facilities in South Korea and the United States,...
Korea’s 40th New Drug ‘Nuviju’ Launches: A Three-Way Battle for the Double-Chin Market

Korea’s 40th New Drug ‘Nuviju’ Launches: A Three-Way Battle for the Double-Chin Market

Medytox is set to shake up the aesthetic medicine industry with the launch of "Nuviju," a new treatment for submental...
Benign Prostatic Hyperplasia Medication Linked to 52% Higher Risk of Acute Glaucoma

Benign Prostatic Hyperplasia Medication Linked to 52% Higher Risk of Acute Glaucoma

A large-scale study in South Korea has revealed that alpha-blockers—the most common treatment for benign prostatic...
Why Breast Cancer Patients Should Get Brain MRIs Even Without Symptoms

Why Breast Cancer Patients Should Get Brain MRIs Even Without Symptoms

Study results suggest that some breast cancer patients should receive regular brain MRI (magnetic resonance imaging)...
Idience Targeted Cancer Drug Candidate ‘Venadaparib’ Granted FDA Fast Track Designation

Idience Targeted Cancer Drug Candidate ‘Venadaparib’ Granted FDA Fast Track Designation

Idience, a novel anticancer drug developer under the Ildong Pharmaceutical Group, announced on the 18th that its...